Related Experiment Videos
Pyridoxal phosphate decreases in plasma but not erythrocytes during systemic inflammatory response
Dinesh Talwar1, Tara Quasim, Donald C McMillan
1Department of Biochemistry, Royal Infirmary, Glasgow G31 2ER, United Kingdom. dtalwar@gribiochem.org.uk
Clinical Chemistry
|February 26, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Optimal Positive Control Assays for Methylation-Specific PCR.
Clinical chemistry·2026
Clinical Utility and Diagnostic Performance of (1→3)-β-D-Glucan in Invasive Mycoses.
Clinical chemistry·2026
Genetic Investigation of X-Linked Defects with Optimized Targeted Long-Read Sequencing.
Clinical chemistry·2026
Extending Quality Control Procedures for Multiplexed Clinical Assays.
Clinical chemistry·2026
Navigating Therapeutic Frontiers: A Meta-review and Meta-analysis of COVID-19 Treatment Options.
Journal of research in pharmacy practice·2026
Population-level benefits of correctional medications for opioid use disorder.
Journal of substance use and addiction treatment·2026
Opioid-Sparing Sedation for Gastrostomy Tube Placement: A Retrospective Cohort Study Comparing Ketamine/Midazolam and Fentanyl/Midazolam.
Journal of vascular and interventional radiology : JVIR·2026
People who use drugs as frontline responders: Rethinking overdose response training through lived experience.
The International journal on drug policy·2026
Inhibition of PARP1-mediated parthanatos by rucaparib phosphate alleviates sepsis-induced acute lung injury.
International immunopharmacology·2026